Fact Check: Insulin Prices Under Trump Have NOT Gone From $600 A Month To $35 A Month -- They Will In 2021 But Only For Seniors With Medicare Part D

Fact Check

  • by: Alexis Tereszcuk
Fact Check: Insulin Prices Under Trump Have NOT Gone From $600 A Month To $35 A Month -- They Will In 2021 But Only For Seniors With Medicare Part D Not Yet

Have insulin prices under President Trump gone from $600 a month to $35 a month? No, the claim takes details out of context. The American Diabetes Association told Lead Stories the $35 price for insulin will apply only to seniors with Medicare Part D drug plan and the lower price will not take effect until 2021. The $35 insulin price does not apply to anyone who is not a senior with this specific drug plan.

The claim appeared as a post published on August 23, 2020, on Facebook (archived here) with following text:

Old Price for Insulin $600.00 a mos New price $35.00 a mos. Outstanding job President Trump!

This is what the post looked like on Facebook at the time of writing:

Facebook screenshot

(Source: Facebook screenshot taken on Thu Aug 27 22:23:39 2020 UTC)

The claim in the Facebook post is likely based on President Trump's announcement about a new Medicare benefit in May, reported by CNN. He said the prescription plan would cap co-pay costs at $35 for insulin for seniors on with Medicare's Part D drug plan.

The White House issued a press release about the plan.

The White House claimed:

LOWERING COST OF INSULIN FOR SENIORS: President Donald J. Trump and his Administration are lowering out-of-pocket insulin costs for Medicare's seniors."

The $35 co-pay plan only applies to the approximately 3.3 million seniors who use one or more of the common forms of insulin and who have the drug plan, the American Diabetes Association confirmed to Lead Stories.

The $35 co-pay does not apply to the millions of other Americans who use insulin. The American Diabetes Association reports "Approximately 7.4 million Americans with diabetes use one or more formulations of insulin."

The cost of insulin varies, the ADA told Lead Stories, but there are reports of people spending as much as $600 a month for their prescription.

The lower price of $35 a month has not taken effect yet as of August 2020. The Senior Savings Model introduced by Trump will begin in January 2021, the ADA confirmed to Lead Stories.

The ADA's statement to Lead Stories said:

The cost of insulin varies for seniors on Medicare depending on their plan and what phase of their drug benefit they are in. Cost sharing changes the more drugs seniors purchase on their plan. Seniors who enroll this fall in Part D plans participating in the Senior Savings Model will pay no more than $35 per 30-day supply of insulin in 2021."

Here is a video of Trump announcing the plan.

President Trump news briefing on protecting seniors.

WATCH LIVE: President Trump news briefing on protecting seniors.

Posted by KCBD NewsChannel 11 on Tuesday, May 26, 2020

Want to inform others about the accuracy of this story?

See who is sharing it (it might even be your friends...) and leave the link in the comments.:

  Alexis Tereszcuk

Alexis Tereszcuk is a writer and fact checker at Lead Stories and an award-winning journalist who spent over a decade breaking hard news and celebrity scoop with RadarOnline and Us Weekly.

As the Entertainment Editor, she investigated Hollywood stories and conducted interviews with A-list celebrities and reality stars.  

Alexis’ crime reporting earned her spots as a contributor on the Nancy Grace show, CNN, Fox News and Entertainment Tonight, among others.

Read more about or contact Alexis Tereszcuk

About Us

International Fact-Checking Organization Meta Third-Party Fact Checker

Lead Stories is a fact checking website that is always looking for the latest false, misleading, deceptive or inaccurate stories, videos or images going viral on the internet.
Spotted something? Let us know!.

Lead Stories is a:


Subscribe to our newsletter

* indicates required

Please select all the ways you would like to hear from Lead Stories LLC:

You can unsubscribe at any time by clicking the link in the footer of our emails. For information about our privacy practices, please visit our website.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices here.

Most Read

Most Recent

Share your opinion